{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:48:40Z","timestamp":1791816520337,"version":"4.3.4"},"reference-count":8,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"DOI":"10.2340\/actadv.v106.adv-2026-0779","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:26:56Z","timestamp":1791815216000},"source":"Crossref","is-referenced-by-count":0,"title":["Molluscum Contagiosum, Warts and Condylomas during JAK Inhibitor Therapy for Atopic Dermatitis: a Retrospective Series of 17 Cases"],"prefix":"10.2340","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3920-8055","authenticated-orcid":false,"given":"Giuseppe","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Tetart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Loretan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Nosbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Raison-Peyron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Burle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Brenaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Saussine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mah\u00e9vas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-David","family":"Bouaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Laffitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jachiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"171130","doi-asserted-by":"crossref","unstructured":"Jarneborn A, Kopparapu PK, Jin T. The Dual-Edged Sword: Risks and benefits Benefits of JAK inhibitors in infections. Pathogens 2025; 14: 324.","DOI":"10.3390\/pathogens14040324"},{"key":"171131","doi-asserted-by":"crossref","unstructured":"Ireland PA, Verheyden M, Jansson N, Sebaratnam D, Sullivan J. Infection risk with JAK inhibitors in dermatoses: a meta-analysis. Int J Dermatol 2025; 64: 24\u201336.","DOI":"10.1111\/ijd.17501"},{"key":"171132","doi-asserted-by":"crossref","unstructured":"Ravlo E, Ianevski A, Skipperst\u00f8en MN, Lysvand H, Schj\u00f8lberg JO, Solheim O, et al. JAK inhibitors remove innate immune barriers facilitating viral propagation. NAR Mol Med 2025; 2: ugaf017.","DOI":"10.1093\/narmme\/ugaf017"},{"key":"171133","doi-asserted-by":"crossref","unstructured":"van der Gang LF, Atash K, Zuithoff NPA, Haeck I, Boesjes CM, Baco\u015f-Cosma OI, et al. Infection risk in atopic dermatitis patients treated with biologics and JAK inhibitors: BioDay results. J Eur Acad Dermatol Venereol 2025; 39: 2056\u20132068.","DOI":"10.1111\/jdv.20674"},{"key":"171134","doi-asserted-by":"crossref","unstructured":"Kinoshita M, Ogawa Y, Kawamura T, Kirito K, Shimada S. Case of disseminated molluscum contagiosum caused by ruxolitinib, a Janus kinase 1 and 2 inhibitor. J Dermatol 2016; 43: 1387\u20131388.","DOI":"10.1111\/1346-8138.13404"},{"key":"171135","doi-asserted-by":"crossref","unstructured":"Seale E, Gavigan G. Exacerbation of human papillomavirus infection with initiation of upadacitinib for atopic dermatitis. JAAD Case Rep 2023; 36: 60\u201362.","DOI":"10.1016\/j.jdcr.2023.04.019"},{"key":"171136","doi-asserted-by":"crossref","unstructured":"Kennoki N, Nohata K, Nakamori Y. Impaired Human Papillomavirus (HPV) clearance in a patient on upadacitinib for atopic dermatitis: A case of refractory genital warts resolved after drug withdrawal. Cureus 2025; 17: e97974.","DOI":"10.7759\/cureus.97974"},{"key":"171137","doi-asserted-by":"crossref","unstructured":"Takahashi N, Shimizu T, Kondoh A, Anzawa K, Shimizu A, Mabuchi T. Human Papilloma Virus Type 94-associated flat warts developing repeatedly during tofacitinib treatment: A case report and review. J Dermatol 2025.","DOI":"10.1111\/1346-8138.17814"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/47009\/55803","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/47009\/55804","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/47009\/55805","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/47009\/55803","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:26:59Z","timestamp":1791815219000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/47009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":8,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2026-0779","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,12]]}}}